Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of DFN-15 (Elyxyb) vs Celebrex in Healthy Adults
NCT03282838Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jun 2017
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib oral solution in migraine (3 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoints: Maximum Plasma Concentration up to 72 hours, Area Under the Curve 0-t up to 72 hours and 1 more. Started Jun 2017; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03282838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282838.